Article
Influence of β2 adrenergic receptor genotype on longitudinal measures of forced vital capacity in patients with Duchenne muscular dystrophy.
Neuromuscular disorders : NMD - 1 Feb 2022
Kelley Eli F, Cross Troy J, McDonald Craig M, Hoffman Eric P, Bello Luca
Abstract excerpt
The progression of decline in forced vital capacity as percent predicated (FVC%p) is a strong indicator of worsening prognosis in patients with Duchenne muscular dystrophy (DMD). Evidence suggests that ß2 adrenergic (ADRB2) receptors may play a role in determining respiratory function, whereby more functional ADRB2 genotype variants (e.g., Gly16) are associated with improved pulmonary function. The purpose of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
